CymitQuimica logo

4-(4-Chlorophenoxy)butyric acid

CAS:

Ref. 3D-FC54216

1g
Discontinued
2g
Discontinued
5g
Discontinued
10g
Discontinued
25g
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

4-(4-Chlorophenoxy)butyric acid
Biosynth

Product Information

Name:4-(4-Chlorophenoxy)butyric acid
Controlled Product
Brand:Biosynth
Description:4-(4-Chlorophenoxy)butyric acid (4CBA) is a nitrobenzodiazepine derivative. It has been shown to bind to the benzodiazepine receptor at the same site as benzodiazepines, but with a different conformation. This drug has been shown to be an effective treatment for anxiety, but not depression. In addition, 4CBA has been shown to interact with GABA receptors and modulate their activity. It also appears that this drug may be useful in the treatment of epilepsy and other neurological disorders because it can enhance GABAergic transmission. 4CBA binds to the carboxylate site on GABA A receptors and inhibits chloride ion influx, which leads to membrane hyperpolarization. This binding also causes conformational changes in the receptor protein that have an effect on the binding of other ligands at the same site. The molecular modelling techniques used for this research showed that 4CBA binds in a similar manner as benzod
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:214.65 g/mol
Formula:C10H11ClO3
Purity:Min. 95%

Inquiry about discontinued product: 4-(4-Chlorophenoxy)butyric acid

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.